Sakai Yoshihito, Ito Kenyu, Hida Tetsuro, Ito Sadayuki, Harada Atsushi
Department of Orthopaedic Surgery, National Center for Geriatrics and Gerontology, Obu, Japan.
Department of Orthopaedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.
Asian Spine J. 2015 Apr;9(2):254-62. doi: 10.4184/asj.2015.9.2.254. Epub 2015 Apr 15.
Preliminary study.
To assess the association of neuropathic pain with chronic low back pain (LBP) and the effect of pregabalin on neuropathic pain in the elderly.
Of those with chronic LBP, 37% were predominantly presenting with neuropathic pain in young adults. Pregabalin is effective for pain in patients with diabetic neuropathy and peripheral neuralgia. No study has reported on the effects of pregabalin for chronic LBP in elderly patients yet.
Pregabalin was administered to 32 patients (age, ≥65 years) with chronic LBP for 4 weeks. Pain and activities of daily living were assessed using the Neuropathic Pain Screening Questionnaire (NePSQ), the pain DETECT questionnaire, visual analog scale, the Japanese Orthopedic Association score, the short form of the McGill Pain Questionnaire and the Roland Morris Disability Questionnaire. Modic change and spinal canal stenosis were investigated using magnetic resonance imaging.
Altogether, 43.3% of patients had neuropathic pain according to the NePSQ and 15.6% patients had pain according to the pain DETECT. The efficacy rate of pregabalin was 73.3%. A significant effect was observed in patients with neuropathic pain after 4 weeks of administration.
Neuropathic pain was slightly less frequently associated with chronic LBP in the elderly. Pregabalin was effective in reducing pain in patients with chronic LBP accompanied with neuropathic pain. Lumbar spinal stenosis and lower limb symptoms were observed in patients with neuropathic pain. We recommend the use of pregabalin for patients after evaluating a screening score, clinical symptoms and magnetic resonance imaging studies.
初步研究。
评估神经性疼痛与慢性下腰痛(LBP)之间的关联以及普瑞巴林对老年人神经性疼痛的影响。
在慢性LBP患者中,37%的年轻成年人主要表现为神经性疼痛。普瑞巴林对糖尿病性神经病变和周围神经痛患者的疼痛有效。尚无研究报道普瑞巴林对老年慢性LBP患者的影响。
对32例年龄≥65岁的慢性LBP患者给予普瑞巴林治疗4周。使用神经性疼痛筛查问卷(NePSQ)、疼痛DETECT问卷、视觉模拟量表、日本骨科协会评分、麦吉尔疼痛问卷简表和罗兰·莫里斯残疾问卷评估疼痛和日常生活活动。使用磁共振成像研究Modic改变和椎管狭窄。
根据NePSQ,共有43.3%的患者患有神经性疼痛,根据疼痛DETECT,15.6%的患者有疼痛。普瑞巴林的有效率为73.3%。给药4周后,神经性疼痛患者观察到显著效果。
神经性疼痛在老年人慢性LBP中关联频率略低。普瑞巴林对伴有神经性疼痛的慢性LBP患者减轻疼痛有效。神经性疼痛患者观察到腰椎管狭窄和下肢症状。我们建议在评估筛查评分、临床症状和磁共振成像研究后,对患者使用普瑞巴林。